CLEARSIDE BIOMEDICAL INC (CLSD)
US1850631045 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -32.48M | -32.95M | 380.00K | -18.21M | -30.77M | |||
| Depreciation Amortization | 67.00K | 150.00K | 180.00K | 180.00K | 210.00K | |||
| Change In Working Capital | 720.00K | 11.24M | -15.34M | 1.12M | -1.30M | |||
| Interest Paid | N/A | 0.00 | 0.00 | 520.00K | 840.00K | |||
| Other non cash items | 13.56M | 8.20M | 4.06M | 3.79M | 4.79M | |||
| OPERATING CASH FLOW | -18.14M | -13.37M | -10.73M | -13.12M | -27.07M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.78M | -250.00K | 0.00 | -60.00K | -30.00K | |||
| Other Investing Activity | N/A | N/A | 0.00 | N/A | 32.95M | |||
| INVESTING CASH FLOW | -1.78M | -250.00K | 0.00 | -60.00K | 32.93M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 0.00 | -4.35M | -5.00M | |||
| Stock Issued/Repurchased | 1.76M | 700.00K | 23.78M | 12.22M | 13.70M | |||
| Other Financing Activity | -1.35M | 30.64M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 414.00K | 31.33M | 23.78M | 7.87M | 8.70M | |||
| CHANGE IN CASH | -19.50M | 17.71M | 13.05M | -5.31M | 14.56M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -18.14M | -13.37M | -10.73M | -13.12M | -27.07M | |||
| Capital Expenditure | -1.78M | -250.00K | 0.00 | -60.00K | -30.00K | |||
| FREE CASH FLOW | -19.91M | -13.62M | -10.73M | -13.18M | -27.10M | |||
All data in USD